other material
confidence high
sentiment positive
materiality 0.65
MSP Recovery, Inc. (MSPR): Nasdaq/NYSE listing notice — MSP Recovery regains Nasdaq compliance, reports $2M pharma settlement and Nomura waiver
MSP Recovery, Inc.
- Nasdaq confirmed bid price deficiency cured; Class A common stock continues listing on Nasdaq Global Market.
- Reached preliminary $2M settlement in pharmaceutical RICO case; settlement provides data to pursue other manufacturers.
- Ongoing settlement negotiations with P&C insurers and pharma/medical device manufacturers; five P&C settlements in 2024 totaling >$10M.
- Nomura waived up to $4M of promissory note obligations until March 2025 for operations, increasing liquidity.
- Acquired additional MSP claims with >$10.6B paid amount for $2M to enhance recovery efforts.